Ultrastructural Aspects of Autoschizis: A New Cancer Cell Death Induced by the Synergistic Action of Ascorbate/Menadione on Human Bladder Carcinoma Cells
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 25 (3), 183-192
- https://doi.org/10.1080/019131201300343810
Abstract
Scanning and transmission electron microscopy were employed to further characterize the cytotoxic effects of a ascorbic acid/ menadione (or vitamin C/vitamin K3) combination on a human bladder carcinoma T24 cell line. Following 1-h treatment T24 cells display membrane and mitochondrial defects as well as excision of cytoplasmic fragments that contain no organelles. These continuous self-excisions reduce the cell size. Concomitant, nuclear changes, chromatin disassembly, nucleolar condensation and fragmentation, and decreased nuclear volume lead to cell death via a process similar to karyorrhexis and karyolysis. Because this cell death is achieved through a progressive loss of cytoplasm due to self-morsellation, the authors named this mode of cell death autoschizis (from the Greek autos, self, and schizein, to split, as defined in Scanning. 1998; 20: 564-575). This morphological characterization of autoschizic cell death confirms and extends the authors previous reports and demonstrates that this cell death is distinct from apoptosis.Keywords
This publication has 5 references indexed in Scilit:
- Apoptosis Provoked by the Oxidative Stress Inducer Menadione (Vitamin K3) Is Mediated by the Fas/Fas Ligand SystemClinical Immunology, 1999
- The Pathways of Cell Death: Oncosis, Apoptosis, and NecrosisToxicologic Pathology, 1997
- Chapter 1 Anatomical Methods in Cell DeathMethods in Cell Biology, 1995
- Ultrastructure and cell surface studies of cancer cells following vitamin C administrationExperimental and Toxicologic Pathology, 1992
- Antitumor potency of ascorbic, dehydroascorbic or 2, 3-dike-togulonic acid and their action on deoxyribonucleic acidZeitschrift für Krebsforschung und Klinische Onkologie, 1971